Ongentys (opicapone capsules – Neurocrine Biosciences) — Cigna
Parkinson’s disease
Initial criteria
- Patient is currently receiving carbidopa/levodopa therapy; AND
- The medication is prescribed by or in consultation with a neurologist.
Approval duration
1 year